SARS-CoV-2 infection has become a major public health burden and affects many organs
including lungs, kidneys, the liver, and the brain. Although the virus is readily detected and …

INTRODUCTION Mycobacterium tuberculosis (Mtb) is the leading global cause of lethal
infection in humans and accounts for the largest number of drug-resistant infections by a single …

Background After receiving a COVID-19 vaccine, most recipients want to know if they are
protected from infection and for how long. Since neutralizing antibodies are a correlate of …

Background Point-of-care diagnostic devices, such as lateral-flow assays, are becoming
widely used by the public. However, efforts to ensure correct assay operation and result …

Recent reports indicate that the sputum of 80% or more of treatment-naive subjects with
tuberculosis recruited in England or South Africa contained more viable Mycobacterium …

In a Clinical Laboratory Improvement Amendments laboratory setting, we evaluated severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) IgG detection with 4 lateral flow …

The historical view of β-lactams as ineffective antimycobacterials has given way to growing
interest in the activity of this class against Mycobacterium tuberculosis (Mtb) in the presence …

Objectives Pseudomonas aeruginosa is a leading cause of opportunistic infections worldwide,
particularly in healthcare settings, and frequently demonstrates resistance to commonly …

BACKGROUND Control of the tuberculosis (TB) pandemic remains hindered in part by a
lack of simple and accurate measures of treatment efficacy, as current gold standard markers …

Point-of-care lateral-flow assays (LFAs) are becomingly increasingly prevalent for diagnosing
individual patient disease status and surveying population disease prevalence in a timely, …